Ethical Questions Linked to Rare Diseases and Orphan Drugs – A Systematic Review
Jaroslav Kacetl,1 Petra Marešová,2 Raihan Maskuriy,3,4 Ali Selamat5,6 1Department of Linguistics, Faculty of Informatics and Management, University of Hradec Kralove, Hradec Kralove, Czech Republic; 2Department of Economics, Faculty of Informatics and Management, University of Hradec Kralove, Hrad...
Saved in:
Main Authors: | Kacetl J (Author), Marešová P (Author), Maskuriy R (Author), Selamat A (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2020-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rare diseases and orphan drugs
by: Domenica Taruscio, et al.
Published: (2011) -
Development of orphan drugs for rare diseases
by: Han-Wook Yoo
Published: (2024) -
Pricing of orphan drugs in oncology and rare diseases
by: Mark Nuijten, et al.
Published: (2020) -
Advancing orphan drug development for rare diseases
by: Jung Min Ko
Published: (2024) -
Clinical experience with orphan drugs for rare metabolic diseases
by: Alicia Caso-González, et al.
Published: (2022)